Cancer Gene Therapy Market By Therapy (Gene Induced Immunotherapy (Delivery of Cytokines Gene, Delivery of Tumor Antigen Gene), Oncolytic Virotherapy (Adenovirus, Lentivirus, Retro Virus, Adeno Associated Virus, Herpes Simplex Virus, Alpha Virus, Vaccinia Virus, Simian Virus, Others), Gene Transfer (Naked/Plasmid Vectors (Electroporation, Sonoportion, Magnetofection, Gene Gun)), Industry Trends, Estimation & Forecast, 2017 - 2025

Get 20% Free Customization In This Report

October 2018

 ERC 8964

 Formats*:  

Share This Report

Cancer Gene Therapy Market is expected to grow with a CAGR of x.x% during the forecast period of 2018 to 2025.

Cancer takes place as a result of the production of multiple mutations in a single cell that causes it to proliferate out of control. Cancer cells can be differentiated from their usual neighbors on the basis of specific phenotypic changes, such as rapid division rate, attack of new cellular areas, high metabolic rate, and altered shape. The cancer patients who are not cured by surgeries, radiations, and chemotherapies, are treated by gene therapy. Gene therapy is the insertion of a functional gene into the cells of a patient to correct an inborn error of metabolism, in order to alter or repair an acquired genetic abnormality, and to provide a new function to a cell. Owing to high success rate throughout the preclinical and clinical trials, cancer gene therapy is gaining popularity.

Cancer Gene Therapy Market Determinants

Improvised technological advancements, increased adoption of developing genomic technologies such as next generation sequencing (NGS) and high density micro array are some of the major factors that will drive the global cancer gene therapy market in next upcoming years. Additionally, increasing number of cancer cases will increase the demand for gene therapy as an effective personalized treatment choice. However, high cost of gene therapy treatment and unwanted immune responses are the major factors restraining the growth of cancer gene therapy. On the other hand, ethical acceptance of gene therapy for cancers, untapped markets in developing economies and the technological progressions principal to higher adoption rate are expected to provide new paths for the growing of cancer gene therapy market in the future.

Cancer Gene Therapy Segment Analysis

The cancer gene therapy market is segmented by therapy, end user and geography. By type, the cancer gene therapy market is segmented into gene induced immunotherapy, gene transfer and oncolytic virotherapy. On the basis of end user, the cancer gene therapy is segmented into hospitals, diagnostics centers and research institutes. By geography, the cancer gene therapy is categorized as North America, Europe, Asia Pacific and Rest of World.
The key players operating in the global cancer gene therapy market include Adaptimmune, GlaxoSmithKline, Bluebird bio, Inc., Merck, Celgene, Shanghai Sunway Biotech, BioCancell, Shenzhen SiBiono GeneTech, SynerGene Therapeutics, and OncoGenex Pharmaceuticals.

Cancer Gene Therapy Market Key Segments:

• By Therapy

o Gene Induced Immunotherapy
   Delivery of Cytokines Gene
   Delivery of Tumor Antigen Gene

o Oncolytic Virotherapy

   Adenovirus
   Lentivirus
   Retro Virus
   Adeno Associated Virus
   Herpes Simplex Virus
   Alpha Virus
   Vaccinia Virus
   Simian Virus
   Others

o Gene Transfer

   Naked/Plasmid Vectors
   Electroporation
   Sonoportion
   Magnetofection
   Gene Gun

• By End User

   Hospitals
   Diagnostics Centers
   Research Institutes

• By Geography

o North America

   U.S.
   Canada
   Mexico

o Europe

   Germany
   UK
   France
   Spain
   Rest of Europe

o Asia-Pacific

   Japan
   China
   Australia
   India
   Rest of Asia-Pacific

o Rest of World

   Brazil
   South Africa
   Saudi Arabia
   Rest of World

Cancer Gene Therapy Market Players

o OncoGenex Pharmaceuticals
o SynerGene Therapeutics
o Shenzhen SiBiono GeneTech
o BioCancell
o Shanghai Sunway Biotech
o Celgene
o Merck
o Bluebird bio, Inc.
o GlaxoSmithKline
o Adaptimmune

Please fill in the form below to Request for Customized Report
  
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

  
Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    What was the market size of the Cancer Gene Therapy Market in 2017 and the expected market size by 2025, along with the growth rate?
    An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    Which are the largest revenue generating products, services or regions and their comparative growth rate?
    Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    Which are the leading companies in the Cancer Gene Therapy Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options





Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities

Customize

  • We offer 20% free customization on every purchase.

Get in touch!

  +91-844-601-6060


  help@esticastresearch.com